News

2 Minute Medicine12h
SGLT2 inhibitors may delay cognitive impairment in elderly patients with heart failure
In elderly patients 65 years of age or older with heart failure with reduced ejection fraction (HFrEF), regular use of sodium ...
Physician's Weekly21h
SGLT2 Inhibitors More Cardioprotective in Older Patients With Type 2 Diabetes
SGLT2 inhibitors and GLP-1 receptor agonists lower cardiovascular risk in type 2 diabetes, but a recent review suggests that ...
The Cardiology Advisor22h
KRT Risk Lower With SGLT2 Inhibitor vs GLP-1 Receptor Agonist Use in Diabetic CKD
Investigators examined the comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in a real-world setting.